Cubist Systematic Strategies »

Phathom Pharmaceuticals shares owned by Cubist Systematic Strategies

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Cubist Systematic Strategies from 13F filings

Historical chart of Cubist Systematic Strategies investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Cubist Systematic Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Cubist Systematic Strategies

Quarter filed Position value Share count Share price at filing
2024-12-31 $2.3M 283k 8.12
2023-03-31 $12k 1.6k 7.14
2022-09-30 $203k 18k 11.10

More positions owned by Cubist Systematic Strategies

Spdr Gold Tr Gold Shs (GLD)
Oracle Corporation Call Option (ORCL)
Vaneck Etf Trust Gold Miners Etf Call Option (GDX)
Palantir Technologies Cl A Call Option (PLTR)
UnitedHealth Call Option (UNH)
Robinhood Mkts Com Cl A Call Option (HOOD)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Select Sector Spdr Tr Energy Call Option (XLE)
Nebius Group Shs Class A Call Option (NBIS)
Meta Platforms Cl A (META)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Netflix Call Option (NFLX)
Wal-Mart Stores (WMT)

View all positions for Cubist Systematic Strategies

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
Carlyle
BlackRock
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Daniel D. Thurber
Catalys Pacific
Jennifer Ranahan
Catalio Capital Management
Geode Capital Management

View all funds holding Phathom Pharmaceuticals